Fortis Healthcare Limited's majority shareholder Northern TK Venture Pte. Ltd. disclosed a holding of 235,295,895 equity shares in the company as of 31 March 2026. The stake represents 51.9% of the total issued and outstanding shares of Fortis Healthcare Limited.
Northern TK Venture Pte. Ltd. a Singapore-based entity registered under UEN 201714842C, made the annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited. The Fortis scrip trades under the symbol FORTIS on NSE and scrip code 532843 on BSE.
The filing was addressed to the Corporate Communications Department of NSE at its Bandra-Kurla Complex office and the Department of Corporate Services of BSE at its Dalal Street office in Mumbai. Northern TK Venture confirmed that no encumbrance of shares was created during the financial year ended 31 March 2026.
The disclosure was signed by Agarwal Aanchal, Director of Northern TK Venture Pte. Ltd. A copy was forwarded to the Company Secretary and Compliance Officer of Fortis Healthcare Limited. The disclosure letter was dated 2 April 2026.
Northern TK Venture's 51.9% holding represents a majority controlling interest in Fortis Healthcare. The annual disclosure satisfies the continuous reporting obligation under the SEBI takeover code for holders of substantial stakes in listed companies.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.